Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

With Industry Codes In Flux, Decoding Ethics Rules Remains A Challenge

This article was originally published in The Gray Sheet

Executive Summary

Device companies aiming to stay on the good side of federal investigators in their dealings with physicians may need to do more than adhere to the AdvaMed Code of Ethics, according to a lawyer who formerly worked at the Department of Health and Human Services Office of Inspector General

You may also be interested in...



Industry Faces Five Challenges In Climate Of Change, Says AdvaMed Chief

The upcoming presidential election and "mantra of change" has created a climate of urgency for the device industry as it continues to seek greater influence as a policy shaper

Belgium Aims To Drive Biologic Competition Through Tendering

New tendering rules in Belgium aim to improve competition between biosimilars and originators, for example by setting contract durations for tendering contracts and limiting the criteria for such contracts.

EU Bodies Agree On Ways To Future-Proof EMA Funding System

EU ministers say that implementing an appropriate fee structure that is more in line with actual costs will promote innovation in the pharmaceutical sector while ensuring “fair access” to safe and effective medicines for patients.

Latest Headlines
See All
UsernamePublicRestriction

Register

MT026757

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel